These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 240782)

  • 1. Inhibition of phenytoin metabolism by other drugs used in epilepsy.
    Houghton GW; Richens A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):210-6. PubMed ID: 240782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Inhibition of phenytoin metabolism by sulthiame.
    Houghton GW; Richens A
    Br J Pharmacol; 1973 Sep; 49(1):157P-158P. PubMed ID: 4150763
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of quinidine with anticonvulsant drugs.
    Data JL; Wilkinson GR; Nies AS
    N Engl J Med; 1976 Mar; 294(13):699-702. PubMed ID: 1250281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding parameters of phenytoin during monotherapy and polytherapy.
    Pospísil J; Perlík F
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):24-8. PubMed ID: 1348053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.
    Hansen JM; Kristensen M; Skovsted L
    Epilepsia; 1968 Mar; 9(1):17-22. PubMed ID: 4386877
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the inhibition of serum pseudocholinesterase activity in vitro by commonly used drugs.
    Bailey DN; Briggs JR
    Am J Clin Pathol; 2005 Aug; 124(2):226-8. PubMed ID: 16040293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant drug-serum levels in psychiatric patients with seizure disorders. Effects of certain psychotropic drugs.
    Siris JH; Pippenger CE; Werner WL; Masland RL
    N Y State J Med; 1974 Aug; 74(9):1554-6. PubMed ID: 4527066
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.
    Gough H; Goggin T; Bissessar A; Baker M; Crowley M; Callaghan N
    Q J Med; 1986 Jun; 59(230):569-77. PubMed ID: 3092278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin metabolism in pregnancy.
    Kochenour NK; Emery MG; Sawchuk RJ
    Obstet Gynecol; 1980 Nov; 56(5):577-82. PubMed ID: 7432728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences between individuals in human pharmacokinetics. Clinical significance].
    Sjöqvist F
    Munch Med Wochenschr; 1972 Sep; 114(38):1600-8. PubMed ID: 4678410
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.
    Aman MG; Paxton JW; Field CJ; Foote SE
    Am J Ment Defic; 1986 May; 90(6):643-50. PubMed ID: 3717220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K; Ishizaki T; Miura H; Minagawa K
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of phenytoin in saliva and its clinical significance].
    Schmidt D
    Bibl Psychiatr; 1975; (151):49-54. PubMed ID: 1156348
    [No Abstract]   [Full Text] [Related]  

  • 18. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy.
    Olesen OV; Jensen ON
    Dan Med Bull; 1969 May; 16(5):154-8. PubMed ID: 4392189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.